Transcriptomics

Dataset Information

0

MLL-PTD and RUNX1-knockout cooperate to induce MDS phenotypes


ABSTRACT: The MLL-PTD mutation is found in patients with MDS and AML, and not in other hematological malignancies. Previously, we showed that Mll-PTD knock-in heterozygous mice (MllPTD/WT mice) present with several MDS-associated features. However, these phenotypes are insufficient to constitute bona fide MDS. MllPTD/WT mice do not generate MDS or AML in primary or transplant recipient mice. This suggests that additional genetic and/or epigenetic defects are necessary for transformation to MDS or AML. In secondary AML and de novo AML, MLL-PTD mutation is significantly associated with mutations in RUNX1 and with the FLT3-ITD mutations. In fact, the combination of MLL-PTD with the FLT3-ITD allele leads to AML in mice. We combined the MLL-PTD with RUNX1 mutant proteins, in order to generate a new mouse model for MDS. We generated MllPTD/WT/Runx1Flox/Flox/Mx1-Cre mice to model loss-of-function RUNX1 mutations. To test the significance of HIF-1α in this model, we also generated MllPTD/WT/Runx1Flox/Flox/Hif-1αFlox/Flox/Mx1-Cre mice and genetically eliminated Hif-1α expression. We analyzed gene expression variations in the HSPCs comparing the MllPTD/WT/Runx1∆/∆ with or without HIF-1α abrogation.

ORGANISM(S): Mus musculus

PROVIDER: GSE86953 | GEO | 2018/12/23

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2018-12-01 | GSE75608 | GEO
2018-12-25 | GSE83988 | GEO
| PRJNA343076 | ENA
2018-09-30 | E-MTAB-7244 | biostudies-arrayexpress
2011-06-30 | GSE15013 | GEO
2013-09-04 | E-GEOD-50537 | biostudies-arrayexpress
2008-11-22 | E-GEOD-10258 | biostudies-arrayexpress
2020-01-28 | GSE126265 | GEO
2021-12-18 | E-MTAB-11238 | biostudies-arrayexpress
2012-11-29 | E-GEOD-40155 | biostudies-arrayexpress